JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, J.
Right arrow Articles by Rampe, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J.
Right arrow Articles by Rampe, D.

Vol. 299, Issue 1, 290-296, October 2001

Interactions of the Antimalarial Drug Mefloquine with the Human Cardiac Potassium Channels KvLQT1/minK and HERG

Jiesheng Kang, Xiao-Liang Chen, Lin Wang and David Rampe

Drug Safety Evaluation, Aventis Pharmaceuticals, Inc., Bridgewater, New Jersey

Mefloquine is a quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. Mefloquine is widely used in both the treatment and prophylaxis of Plasmodium falciparum malaria. Mefloquine can prolong cardiac repolarization, especially when coadministered with halofantrine, an antagonist of the human ether-a-go-go-related gene (HERG) cardiac K+ channel. For these reasons we examined the effects of mefloquine on the slow delayed rectifier K+ channel (KvQT1/minK) and HERG, the K+ channels that underlie the slow (IKs) and rapid (IKr) components of repolarization in the human myocardium, respectively. Using patch-clamp electrophysiology we found that mefloquine inhibited KvLQT1/minK channel currents with an IC50 value of approximately 1 µM. Mefloquine slowed the activation rate of KvLQT1/minK and more block was evident at lower membrane potentials compared with higher ones. When channels were held in the closed state during drug application, block was immediate and complete with the first depolarizing step. HERG channel currents were about 6-fold less sensitive to block by mefloquine (IC50 = 5.6 µM). Block of HERG displayed a positive voltage dependence with maximal inhibition obtained at more depolarized potentials. In contrast to structurally related drugs such as quinidine, mefloquine is a more effective antagonist of KvLQT1/minK compared with HERG. Block of KvLQT1/minK by mefloquine may involve an interaction with the closed state of the channel. Inhibition by mefloquine of KvLQT1/minK in the human heart may in part explain the synergistic prolongation of QT interval observed when this drug is coadministered with the HERG antagonist halofantrine.

0022-3565/01/2991-0290$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
M. Eijgelsheim, A. L.H.J. Aarnoudse, F. Rivadeneira, J. A. Kors, J. C. M. Witteman, A. Hofman, C. M. van Duijn, A. G. Uitterlinden, and B. H.C. Stricker
Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration
Hum. Mol. Genet., January 15, 2009; 18(2): 347 - 357.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. R. Best and W. G. Regehr
Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses
J. Neurosci., June 18, 2008; 28(25): 6508 - 6515.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Wozniacka, I Cygankiewicz, M Chudzik, A Sysa-Jedrzejowska, and J. Wranicz
The Cardiac Safety of Chloroquine Phosphate Treatment in Patients with Systemic Lupus Erythematosus: The Influence on Arrhythmia, Heart Rate Variability and Repolarization Parameters
Lupus, August 1, 2006; 15(8): 521 - 525.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. J. Cruikshank, M. Hopperstad, M. Younger, B. W. Connors, D. C. Spray, and M. Srinivas
Potent block of Cx36 and Cx50 gap junction channels by mefloquine
PNAS, August 17, 2004; 101(33): 12364 - 12369.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. B. Appel, Z. Liu, M. A. McElvain, and M. S. Brodie
Ethanol Excitation of Dopaminergic Ventral Tegmental Area Neurons Is Blocked by Quinidine
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 437 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
W.S. Redfern, L. Carlsson, A.S. Davis, W.G. Lynch, I. MacKenzie, S. Palethorpe, P.K.S. Siegl, I. Strang, A.T. Sullivan, R. Wallis, et al.
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
Cardiovasc Res, April 1, 2003; 58(1): 32 - 45.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Sanchez-Chapula, R. A. Navarro-Polanco, C. Culberson, J. Chen, and M. C. Sanguinetti
Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block
J. Biol. Chem., June 21, 2002; 277(26): 23587 - 23595.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.